Trial Profile
Therapeutic Effects of Mesalamine and Amitriptyline in IBS: a Randomized Clinical Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Amitriptyline
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 14 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment due to lack of volunteer patients.
- 13 Nov 2014 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 13 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.